| Melanoma | hsa05218 | 6.56 |
| Platelet activation | hsa04611 | 5.66 |
| Fc gamma R-mediated phagocytosis | hsa04666 | 6.21 |
| Small cell lung cancer | hsa05222 | 6.17 |
| cGMP-PKG signaling pathway | hsa04022 | 5.32 |
| Natural killer cell mediated cytotoxicity | hsa04650 | 5.53 |
| Colorectal cancer | hsa05210 | 6.52 |
| Renal cell carcinoma | hsa05211 | 6.6 |
| Jak-STAT signaling pathway | hsa04630 | 5.44 |
| Signaling pathways regulating pluripotency of stem cells | hsa04550 | 5.6 |
| cAMP signaling pathway | hsa04024 | 5.05 |
| Prostate cancer | hsa05215 | 6.11 |
| Leukocyte transendothelial migration | hsa04670 | 5.74 |
| Cholinergic synapse | hsa04725 | 5.88 |
| Choline metabolism in cancer | hsa05231 | 6.09 |
| FoxO signaling pathway | hsa04068 | 5.63 |
| Osteoclast differentiation | hsa04380 | 5.64 |
| HIF-1 signaling pathway | hsa04066 | 5.9 |
| Chemokine signaling pathway | hsa04062 | 5.19 |
| Oxytocin signaling pathway | hsa04921 | 5.4 |
| Aldosterone-regulated sodium reabsorption | hsa04960 | 7.41 |
| VEGF signaling pathway | hsa04370 | 6.77 |
| Focal adhesion | hsa04510 | 4.92 |
| Endometrial cancer | hsa05213 | 6.81 |
| Type II diabetes mellitus | hsa04930 | 7.12 |
| Progesterone-mediated oocyte maturation | hsa04914 | 6.18 |
| Chagas disease (American trypanosomiasis) | hsa05142 | 5.99 |
| Pancreatic cancer | hsa05212 | 6.56 |
| Amoebiasis | hsa05146 | 5.82 |
| Epstein-Barr virus infection | hsa05169 | 4.97 |
| Toxoplasmosis | hsa05145 | 5.71 |
| Influenza A | hsa05164 | 5.21 |
| Apoptosis | hsa04210 | 6.23 |
| HTLV-I infection | hsa05166 | 4.59 |
| PI3K-Akt signaling pathway | hsa04151 | 4.21 |
| Hepatitis C | hsa05160 | 5.68 |
| Hepatitis B | hsa05161 | 5.52 |
| Measles | hsa05162 | 5.6 |
| B cell receptor signaling pathway | hsa04662 | 6.52 |
| Chronic myeloid leukemia | hsa05220 | 6.48 |
| Bacterial invasion of epithelial cells | hsa05100 | 6.34 |
| Proteoglycans in cancer | hsa05205 | 5.02 |
| Toll-like receptor signaling pathway | hsa04620 | 6.0 |
| Pathways in cancer | hsa05200 | 3.98 |
| Viral carcinogenesis | hsa05203 | 5.08 |
| T cell receptor signaling pathway | hsa04660 | 6.01 |
| Phosphatidylinositol signaling system | hsa04070 | 6.38 |
| Rap1 signaling pathway | hsa04015 | 4.97 |
| Ras signaling pathway | hsa04014 | 4.9 |
| Inflammatory mediator regulation of TRP channels | hsa04750 | 6.07 |
| Prolactin signaling pathway | hsa04917 | 6.6 |
| Acute myeloid leukemia | hsa05221 | 6.74 |
| Estrogen signaling pathway | hsa04915 | 6.11 |
| TNF signaling pathway | hsa04668 | 5.96 |
| Thyroid hormone signaling pathway | hsa04919 | 5.82 |
| AMPK signaling pathway | hsa04152 | 5.8 |
| mTOR signaling pathway | hsa04150 | 6.72 |
| Regulation of actin cytoskeleton | hsa04810 | 4.9 |
| Carbohydrate digestion and absorption | hsa04973 | 7.28 |
| Non-small cell lung cancer | hsa05223 | 6.88 |
| Insulin signaling pathway | hsa04910 | 5.55 |
| Neurotrophin signaling pathway | hsa04722 | 5.78 |
| Non-alcoholic fatty liver disease (NAFLD) | hsa04932 | 5.51 |
| Central carbon metabolism in cancer | hsa05230 | 6.7 |
| Glioma | hsa05214 | 6.66 |
| Fc epsilon RI signaling pathway | hsa04664 | 6.6 |
| Adrenergic signaling in cardiomyocytes | hsa04261 | 5.44 |
| ErbB signaling pathway | hsa04012 | 6.15 |